{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:16:57Z","timestamp":1791231417677,"version":"4.1.0"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202913"],"award-info":[{"award-number":["82202913"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372996"],"award-info":[{"award-number":["82372996"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Natural Science Foundation of Chongqing Municipality","doi-asserted-by":"publisher","award":["CSTB 2023 NSCQ-MSX0480"],"award-info":[{"award-number":["CSTB 2023 NSCQ-MSX0480"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Female-specific cancers (FSCs) impose substantial burdens on healthcare systems and economies worldwide. The significant impact of these cancers in the United States warrants further investigation.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Objective<\/jats:title>\n<jats:p>This study aimed to analyze trends in incidence and mortality rates of six female-specific cancers (breast, cervical, uterine, ovarian, vaginal, and vulvar cancers) among diverse racial and ethnic groups in the United States, and to evaluate the attributable contributions of major risk factors to the cancer death burden as well as their temporal changes.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Incidence and mortality data were obtained from the SEER (22 registry) database, to examine cross-sectional and temporal trends by race\/ethnicity. The burden of FSCs attributable to specific risk factors was estimated based on the Global Burden of Disease 2021 database.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Results<\/jats:title>\n<jats:p>Between 2017 and 2021, Breast cancer incidence increased across all racial groups, most notably among non-Hispanic White (White) women, while mortality declined. Cervical cancer incidence decreased in most groups but remained stable among American Indians and Alaska Native (AIAN) women. Uterine cancer incidence increased across all racial groups, except for Whites. Incidence and mortality rates for ovarian and vaginal cancers remained stable or decreased, whereas vulvar cancer mortality was highest among White and AIAN women and lowest among non-Hispanic Asian Americans and Pacific Islander (AAPI) women. From 2000 to 2021, risk-attributable deaths decreased for breast, cervical, and ovarian cancers but increased for uterine cancer.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec005\">\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Significant sociodemographic disparities and unfavorable trends persist in the incidence and mortality of all six major female-specific cancers, highlighting the importance for effective prevention and intervention strategies.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0334128","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T17:36:17Z","timestamp":1760463377000},"page":"e0334128","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Disparities and trends of the incidence and mortality of female-specific cancers in the United States"],"prefix":"10.1371","volume":"20","author":[{"given":"Ze","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuquan","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6545-0945","authenticated-orcid":true,"given":"Fan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"issue":"3","key":"pone.0334128.ref001","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"pone.0334128.ref002","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"RL Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"issue":"12","key":"pone.0334128.ref003","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/jnci\/djab192","article-title":"Annual report to the nation on the status of cancer, part 2: patient economic burden associated with cancer care","volume":"113","author":"KR Yabroff","year":"2021","journal-title":"J Natl Cancer Inst"},{"issue":"5","key":"pone.0334128.ref004","first-page":"461","article-title":"Social determinants of health and US cancer screening interventions: a systematic review","volume":"73","author":"AR Korn","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"pone.0334128.ref005","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/cncr.34503","article-title":"Trends in breast cancer mortality by race\/ethnicity, age, and US census region, United States\u25001999-2020","volume":"129","author":"TD Ellington","year":"2023","journal-title":"Cancer"},{"key":"pone.0334128.ref006","volume-title":"SEER*Stat Database: Incidence - SEER Research Data, 8 Registries, Nov 2023 Sub (1975-2021) - Linked To County Attributes - Time Dependent (1990-2022) Income\/Rurality, 1969-2022","author":"Surveillance, Epidemiology, and End Results (SEER) Program","year":"2024"},{"issue":"6","key":"pone.0334128.ref007","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.14309\/ajg.0000000000003198","article-title":"Disparities, trends, and predictions to 2040 in gastrointestinal cancer incidence, mortality in the United States","volume":"120","author":"Y Huang","year":"2024","journal-title":"Am J Gastroenterol"},{"issue":"9","key":"pone.0334128.ref008","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx030","article-title":"Annual report to the nation on the status of cancer, 1975-2014, featuring survival","volume":"109","author":"A Jemal","year":"2017","journal-title":"J Natl Cancer Inst"},{"issue":"10352","key":"pone.0334128.ref009","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(22)01438-6","article-title":"The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019","volume":"400","author":"GBD 2019 Cancer Risk Factors Collaborators","year":"2022","journal-title":"Lancet"},{"key":"pone.0334128.ref010","doi-asserted-by":"crossref","first-page":"102713","DOI":"10.1016\/j.eclinm.2024.102713","article-title":"Global, regional, and national burden of female cancers in women of child-bearing age, 1990-2021: analysis of data from the global burden of disease study 2021","volume":"74","author":"P Sun","year":"2024","journal-title":"EClinicalMedicine"},{"issue":"1","key":"pone.0334128.ref011","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.eururo.2022.11.023","article-title":"Disparities and trends in genitourinary cancer incidence and mortality in the USA","volume":"84","author":"EJ Schafer","year":"2023","journal-title":"Eur Urol"},{"key":"pone.0334128.ref012","volume-title":"SEER*Stat software version 8.4.4","author":"Surveillance Research Program","year":"2024"},{"issue":"6","key":"pone.0334128.ref013","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1177\/0962280206070621","article-title":"Efficient interval estimation for age-adjusted cancer rates","volume":"15","author":"RC Tiwari","year":"2006","journal-title":"Stat Methods Med Res"},{"issue":"3","key":"pone.0334128.ref014","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"HJ Kim","year":"2000","journal-title":"Stat Med"},{"issue":"4","key":"pone.0334128.ref015","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2307\/2530689","article-title":"The natural variability of vital rates and associated statistics","volume":"42","author":"DR Brillinger","year":"1986","journal-title":"Biometrics"},{"issue":"6","key":"pone.0334128.ref016","first-page":"342","article-title":"Trends in breast cancer by race and ethnicity","volume":"53","author":"A Ghafoor","year":"2003","journal-title":"CA Cancer J Clin"},{"issue":"18","key":"pone.0334128.ref017","doi-asserted-by":"crossref","first-page":"4132","DOI":"10.1002\/cncr.26019","article-title":"Impact of body mass index on clinical outcomes in triple-negative breast cancer","volume":"117","author":"FO Ademuyiwa","year":"2011","journal-title":"Cancer"},{"issue":"1","key":"pone.0334128.ref018","first-page":"35","article-title":"Disparities across the breast cancer continuum","volume":"16","author":"J Bigby","year":"2005","journal-title":"Cancer Causes Control"},{"issue":"6","key":"pone.0334128.ref019","first-page":"456","article-title":"The relationship of rural persons\u2019 multidimensional health locus of control to knowledge of cancer, cancer myths, and cancer danger signs","volume":"22","author":"P Winstead-Fry","year":"1999","journal-title":"Cancer Nurs"},{"issue":"21","key":"pone.0334128.ref020","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1001\/jama.295.21.2492","article-title":"Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study","volume":"295","author":"LA Carey","year":"2006","journal-title":"JAMA"},{"issue":"10","key":"pone.0334128.ref021","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1158\/1055-9965.EPI-12-0479","article-title":"Patient navigation significantly reduces delays in breast cancer diagnosis in the District of Columbia","volume":"21","author":"HJ Hoffman","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prevent"},{"issue":"1","key":"pone.0334128.ref022","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1038\/s41597-023-02253-5","article-title":"Global trends and forecasts of breast cancer incidence and deaths","volume":"10","author":"Y Xu","year":"2023","journal-title":"Sci Data"},{"issue":"3","key":"pone.0334128.ref023","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/ije\/dyz273","article-title":"Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic","volume":"49","author":"Y Wang","year":"2020","journal-title":"Int J Epidemiol"},{"issue":"6","key":"pone.0334128.ref024","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0025-7125(05)70174-7","article-title":"Breast cancer screening","volume":"83","author":"B Overmoyer","year":"1999","journal-title":"Med Clin North Am"},{"key":"pone.0334128.ref025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ygyno.2022.11.007","article-title":"Persistent disparities of cervical cancer among American Indians\/Alaska natives: Are we maximizing prevention tools?","volume":"168","author":"AS Bruegl","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"1","key":"pone.0334128.ref026","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/infdis\/jiu394","article-title":"Disparity in the persistence of high-risk human papillomavirus genotypes between African American and European American women of college age","volume":"211","author":"CE Banister","year":"2015","journal-title":"J Infect Dis"},{"issue":"2","key":"pone.0334128.ref027","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(22)00501-0","article-title":"Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO Global Cervical Cancer Elimination Initiative","volume":"11","author":"D Singh","year":"2023","journal-title":"Lancet Glob Health"},{"issue":"18","key":"pone.0334128.ref028","doi-asserted-by":"crossref","first-page":"475","DOI":"10.15585\/mmwr.mm7218a1","article-title":"Tobacco product use among adults - United States, 2021","volume":"72","author":"ME Cornelius","year":"2023","journal-title":"MMWR Morbidity Mortality Weekly Report"},{"issue":"48","key":"pone.0334128.ref029","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.15585\/mmwr.mm6748a1","article-title":"Uterine cancer incidence and mortality - United States, 1999-2016","volume":"67","author":"SJ Henley","year":"2018","journal-title":"MMWR Morbidity Mortality Weekly Report"},{"issue":"22","key":"pone.0334128.ref030","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1200\/JCO.19.00151","article-title":"Hysterectomy-corrected uterine corpus cancer incidence trends and differences in relative survival reveal racial disparities and rising rates of nonendometrioid cancers","volume":"37","author":"MA Clarke","year":"2019","journal-title":"J Clin Oncol"},{"issue":"12","key":"pone.0334128.ref031","doi-asserted-by":"crossref","first-page":"4646","DOI":"10.1111\/cas.14667","article-title":"A Mendelian randomization study identified obesity as a causal risk factor of uterine endometrial cancer in Japanese","volume":"111","author":"T Masuda","year":"2020","journal-title":"Cancer Sci"},{"issue":"4","key":"pone.0334128.ref032","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1007\/s11695-019-04368-4","article-title":"Effects of bariatric surgery on cancer risk: evidence from meta-analysis","volume":"30","author":"K Zhang","year":"2020","journal-title":"Obes Surg"},{"issue":"5","key":"pone.0334128.ref033","first-page":"365","article-title":"Trends in hormone use and ovarian cancer incidence in US white and Australian women: implications for the future","volume":"28","author":"PM Webb","year":"2017","journal-title":"Cancer Causes Control"},{"issue":"11","key":"pone.0334128.ref034","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/annonc\/mdw411","article-title":"Ovarian cancer mortality trends: which factors are involved?","volume":"27","author":"E Weiderpass","year":"2016","journal-title":"Ann Oncol"},{"issue":"9","key":"pone.0334128.ref035","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1038\/s43018-023-00617-9","article-title":"Clinical and translational advances in ovarian cancer therapy","volume":"4","author":"PA Konstantinopoulos","year":"2023","journal-title":"Nat Cancer"},{"issue":"3","key":"pone.0334128.ref036","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/ijc.30115","article-title":"Obesity, weight gain, and ovarian cancer risk in African American women","volume":"139","author":"EV Bandera","year":"2016","journal-title":"Int J Cancer"},{"issue":"6","key":"pone.0334128.ref037","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines","volume":"107","author":"M Saraiya","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"pone.0334128.ref038","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/cncr.23757","article-title":"Descriptive epidemiology of vaginal cancer incidence and survival by race, ethnicity, and age in the United States","volume":"113","author":"X Wu","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"pone.0334128.ref039","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1006\/gyno.2001.6502","article-title":"A population-based study of squamous cell vaginal cancer: HPV and cofactors","volume":"84","author":"JR Daling","year":"2002","journal-title":"Gynecol Oncol"},{"key":"pone.0334128.ref040","doi-asserted-by":"crossref","first-page":"1605021","DOI":"10.3389\/ijph.2022.1605021","article-title":"Trends in the incidence of vulvar and vaginal cancers with different histology by race, age, and region in the United States (2001-2018)","volume":"67","author":"W-L Zhou","year":"2022","journal-title":"Int J Public Health"},{"issue":"33","key":"pone.0334128.ref041","doi-asserted-by":"crossref","first-page":"918","DOI":"10.15585\/mmwr.mm6733a2","article-title":"Trends in human papillomavirus-associated cancers - United States, 1999-2015","volume":"67","author":"EA Van Dyne","year":"2018","journal-title":"MMWR Morbidity Mortality Weekly Report"},{"key":"pone.0334128.ref042","doi-asserted-by":"crossref","first-page":"107302","DOI":"10.1016\/j.ypmed.2022.107302","article-title":"Trends in HPV- and non-HPV-associated vulvar cancer incidence, United States, 2001-2017","volume":"164","author":"JM Mix","year":"2022","journal-title":"Prev Med"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334128","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T17:36:25Z","timestamp":1760463385000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0334128"}},"subtitle":[],"editor":[{"given":"Kehinde S.","family":"Okunade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":42,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,14]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0334128","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]}}}